fbpx

NOVEL ANTI-CANCER SCREENING LIBRARIES

NOVEL ANTI-CANCER SCREENING LIBRARIES

Compounds available in 96/384w plates as DMSO solutions or Dry powders.

background
Novel Anti-Cancer Screening libraries
Compounds available in 96/384w plates as DMSO solutions or Dry powders.
> MCL1 Targeted Library
Induced myeloid leukemia cell differentiation protein Mcl-1 targeted library; 12,000 compounds
Description, Slides
Structures, SDF
> Arginase targeted Library
Implicated in cancer immunosuppression and cancer tumor growth; 2,000 compounds
Description, Slides
Structures, SDF
> Chelators targeting matrix metalloproteinases
MMPs require coordination of a zinc ion to mediate catalysis; 9,300 compounds
Description, Slides
Structures, SDF
> Complete List of Our Targeted and Focused Compound Libraries
(CNS MPO, RNA targeted, Anti-Aging, Kinases and other 120 libraries)
Description. Slides
Structures, SDF
> ChemDiv’s STOCK compound collection
(Innovative, Discovery and New Chemistry collections 1,600,000 compounds)
Description, Slides
Structures, SDF
> ChemDiv’s Building blocks collection
(Unique building blocks collection, 80,329 compounds)
Description, Slides
Structures, SDF
Drug Discovery solutions
> High Throughput Screening Services
(HTS assay set-up, validation and screening)
Click Here
> Synthetic and Medicinal Chemistry Services
(Hit-to-Lead Optimization, Lead-optimization or Custom library synthesis)
Click Here
> Computational Chemistry Services
(Scaffold Hopping, AI-assisted target deconvolution, QSAR Modeling & other services)
Click Here
> Compound Profiling
(ADME, PK, TOX & other assays)
Click Here
OUR MOST POPULAR SCREENING LIBRARIES
In addition to our newest compound collections, please take a look at our most popular libraries:
Anti-Infective Library (20,600 Compounds) Structures
HDAC Targeted Library (9,500 Compounds) Structures
Annotated BioActive Screening Collections (99,500 Compounds) Structures
HDAC Targeted Library (9,500 Compounds) Structures
PTPN Targeted Library (33,000 compounds) Structures
CORONAVIRUS Library (13,000 compounds) Structures
Lipid Metabolism Library (9,000 compounds) Structures
PPI 2.0 Library (PPI Modulators; 210,000 compounds) Structures
Diverse Libraries (Diversity from our 1,6M STOCK ; 50,000 compounds) Structures
Anti-Fungal Library (Targeting fungal proteins; 18,000 compounds) Structures
Integrin Receptors Targeted (Focus on RGD domain; 1,920 compounds) Structures
DNA/RNA Targeted Library (RNA/DNA/miRNA as a target; 9,200 compounds) Structures
Covalent Inhibitors Library (Must-have library for any HTS; 5,800 compounds) Structures
Antimitotic Tubulin Library (Anti-Cancer library; 19,300 compounds) Structures
Beyond-the-Flatland library (Fsp3 rich library; 65,000 compounds) Structures
Epigenetics libraries (KDM, HDAC, DNMT, EPI set; 99,000 compounds) Structures
Angiogenesis library (VEGFR, FLT3, PDGFR, EGFR etc.; 16,000 compounds) Structures
Autophagy targeted library (Autophagy modulators; 16,000 compounds) Structures
Natural Products Based library (Matrine, Cytisine etc.;4,000 compounds) Structures
Anti-Viral library Trained on hits/leads from 50 viral species; 80,000 compounds) Structures
GPCR Targeted library (ANN-based model; 37,000 compounds) Structures
CNS library (Kohonen networks; 16,000 compounds) Structures
Anti-Cancer library (Target and Scaffold hopping; 67,000 compounds) Structures
Anti-Inflammatory library (Kohonen networks; 27,000 compounds) Structures
OUR STOCK AVAILABLE COMPOUND COLLECTIONS
> Structures of ChemDiv’s Stock Compound Collection Click Here
> Building Blocks collection, more than 74,329 unique building blocks Click Here
> Complete List of Our Targeted and Focused Compound Libraries Click Here
We will be happy to hear your requests, comments or questions at LT@chemdiv.com or chemdiv@chemdiv.com
June 3, 2020 / Blog
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X